Video - IMPACT Trial Explained
Determining the patient benefit that could be achieved by adding an inhaled corticosteroid to dual bronchodilator therapy.
Internet Explorer is no longer supported.
To provide you with the best possible experience, please switch to a supported browser e.g.
has been added to your basket
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
October 2022 | PM-GB-FVU-WCNT-200015 (V5.0)